MASA Valve Early Feasibility Study

Status Recruiting

Clinical Trial Summary

The MASA Valve Early Feasibility Study (MVEFS) multi-site interventional clinical trial within the United States of America with each center following a common protocol.The objective of the trial is to evaluate the safety and probable benefit of MASA Valve in the indicated subset of patients requiring Right Ventricular Outflow Tract Reconstruction (RVOTR). As an early feasibility study, the purpose is determine the feasibility of success of the device in order to gather early data towards a future pivotal study and/or regulatory clearance submission.

Clinical Trial Description

The MASA Valve is a bi-leaflet pulmonary valved conduit. The MASA Valve has an ePTFE conduit and ePTFE leaflets fixtured to the conduit with polypropylene suture. The device has a pad-printed design on the outer conduit surface indicating the valve position and direction of flow. . The MASA Valve is intended to be used to reconstruction the Right Ventricular Outflow Tract (RVOT) and provide a functional pulmonary valve. Once implanted, the MASA Valve provides a pathway for blood from the Right Ventricle (RV) to the Pulmonary Arteries (PAs), while the integrated valve helps to prevent backflow into the RV. The MASA Valve Indications for Use are: The MASA Valve pulmonary valved conduit is indicated for correction or reconstruction of the right ventricular outflow tract (RVOT) in patients aged less than 22 years with any of the following congenital cardiac malformations: - Pulmonary Stenosis - Tetralogy of Fallot - Truncus Arteriosus - Transposition of Great Vessels - Pulmonary Atresia In addition, the MASA Valve is indicated for the replacement of previously implanted, but dysfunctional, pulmonary valves, valved conduits or conduits, as well as for use in the Ross Procedure when the native RVOT is being used to reconstruct the Aorta. Treatments currently available for the above-stated conditions include biologic-tissue-based valved conduits (Homografts and Contegra Glutaraldehyde-fixed Bovine Jugular Vein), Intra-operatively constructed valved conduits made from off-the-shelf vascular grafts and cardiovascular membranes, and non-valved cardiovascular conduits. Based on existing evidence it is believed the potential benefits of MASA Valve outweigh the potential risks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05452720
Study type	Interventional
Source	PECA Labs
Contact	Arush Kalra, MBBS, MS
Phone	4123300746
Email	arush@pecalabs.com
Status	Recruiting
Phase	N/A
Start date	May 18, 2023
Completion date	April 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05524324` - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT	N/A
Recruiting	`NCT04616222` - A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels
Completed	`NCT03833843` - Sudden Cardiac Death in Systemic Right Ventricle
Active, not recruiting	`NCT02588989` - Fibrosis, Valvular and Ventricular Function in Patients With TGA
Recruiting	`NCT04106479` - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Active, not recruiting	`NCT04335448` - Comprehensive Long-term Follow up of Adults With Arterial Switch Operation
Completed	`NCT01916499` - MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries	N/A
Completed	`NCT03078413` - Late Function After Surgery for Transposition of the Great Arteries
Completed	`NCT00199771` - Hypertonic Saline Dextran in Pediatric Cardiac Surgery	Phase 2
Completed	`NCT00703352` - Eplerenone in Systemic Right Ventricle	Phase 4
Completed	`NCT00006183` - Comparison of Hematocrit Levels in Infant Heart Surgery	Phase 3
Completed	`NCT00005190` - Reproduction and Survival After Cardiac Defect Repair	N/A
Completed	`NCT03661385` - Nitric Oxide During Bypass for Arterial Switch Operation	Phase 3
Completed	`NCT00837603` - Physical Training in Transposition of the Great Arteries	N/A
Completed	`NCT00374088` - N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)	Phase 2
Completed	`NCT00000470` - Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest	Phase 3
Completed	`NCT05160116` - Influence of Timing of Switch Operation in Transposition of Great Arteries
Completed	`NCT05089773` - Outcomes of Transposition of the Great Arteries After Arterial Switch Operation
Recruiting	`NCT05809310` - Effects Branch PA Stenting d-TGA, ToF and TA	N/A
Not yet recruiting	`NCT04288596` - Canadian Adult Congenital Heart Disease Intervention Registry

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

MASA Valve Early Feasibility Study — MVEFS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms